RECONOCIMIENTOS

Un equipo de especialistas en biotecnología enfocado en el desarrollo
de pruebas diagnósticas para enfermedades neurodegenerativas.

 

Consejo Científico Asesor

 

European Comission

ADRisk Project. A New Non-Genetic Method to Evaluate Alzheimer’s Disease Risk Using Clinical Chemistry Analyzers – 2018 – Horizon 2020, the EU Framework Programme for Research and Innovation 2014-2020 – European Commission.
(Download pdf)

Genoma España

Development of a diagnostic system for Alzheimer’s disease – 2013 – Innocash (Genoma España)
The main objective is to develop a product that enables diagnosis of Alzheimer’s disease from blood samples with a sensitivity and specificity higher than that of any currently available method (>85%).

Centro para el Desarrollo Tecnológico Industrial

Innovative solutions to accelerate the identification and development of drugs for diseases of the nervous system – 2011 – CENIT (CDTI)
To develop new experimental and technological approaches to identify candidate compounds for future therapies for nervous system diseases.

Instituto Madrileño de Desarrollo

Investigation of a process for early detection of Alzheimer’s disease – 2009 – IMADE
The aim of this project is to develop and commercialize new products for the non-invasive diagnosis of Alzheimer’s disease. These will allow diagnosis of this disease at much earlier stages than currently possible, with greater reliability and less disruption to patients

Ministerio de Economía y Competitividad

A novel two step blood test for the early diagnosis of Alzheimer disease – 2015 – MINECO
Tiene como objetivo validar un test diagnóstico para la enfermedad de Alzheimer (AD) basado en marcadores previamente identificados en la sangre.
(Download pdf)

Ministerio de Economía y Competitividad

Design and construction of a system for diagnosing Alzheimer’s disease based on laser raman spectroscopy – 2012 – INNPACTO (MINECO).

Centro para el Desarrollo Tecnológico Industrial

Development of a prototype of a high resolution diagnostic test blood for Alzheimer’s disease – 2010 – CDTI
The main objective of the project is to develop a prototype of a diagnostic blood test that will enable clinical diagnosis of Alzheimer’s disease with greater accuracy than currently available